INSIGHTS ON CLINICAL TRIAL DESIGN
-
Operationalizing Immuno-Oncology Studies
Managing CRS and immune risks demands early detection, rapid response, and skilled teams. Strong infrastructure and clear protocols enable safer immunotherapy trials beyond academic centers.
-
Decentralized Clinical Trials: FDA Guidance Analyzed
Explore the evolution of the FDA decentralized clinical trial (DCT) guidance, highlighting key updates on responsibilities, data variability, inspections, and trial design.
-
Beyond The Benchmark: Innovative Trial Designs Transform Research
Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
-
Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM
Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early.
-
Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk2/24/2026
Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment Landscape9/14/2026
See how rapid site activation, strong oncology site relationships, and adaptive protocol management kept a complex global cancer trial on track amid evolving standards of care.
-
8 Critical Questions To Ask Your IRB2/5/2025
This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.
-
Planning For Clinical Trial Chaos8/28/2026
Clinical study management has fundamentally changed. This video explores why the traditional top-heavy approach must give way to more efficient, adaptable products.
-
No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure1/14/2026
This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.
-
Modern RTSM capabilities help streamline study execution, support compliance, and provide greater visibility across complex global clinical trials.
-
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.